iGEM and After iGEM: Enabling change-makers through synthetic biology

February 14, 2019

The International Genetically Engineered Machine (iGEM) Foundation is an independent, non-profit organization dedicated to the advancement of synthetic biology, education and competition, and the development of an open community and collaboration. The iGEM competition provides students around the globe with the opportunity to pursue projects that address unique challenges within their local community within a…

Read More

Revealing Hidden Mysteries with Ancient DNA

February 14, 2019

Lakehead University’s Paleo-DNA Laboratory was born out of necessity. Back in 1996, there were no laboratories that performed DNA analysis on archaeological samples (paleo or ancient DNA) on a fee for service basis. Anthropology professor Dr. El Molto, who had acquired vast amounts of human material from his site in the Dahkleh Oasis, Egypt, had…

Read More

Major investment in genomics research will improve the lives of Canadians

February 4, 2019

The Honourable Kirsty Duncan, Minister of Science and Sport, announced $22.7 million funding to support 37 research projects as a result of three funding competitions through Genome Canada. An additional $33.4 million is being invested by provincial governments, business and research partners for a total of $56 million in support for these projects spanning sectors such as health, agriculture, natural resources, and the environment.

Read More

Ignite your Proteomics Research with SPARC BioCentre

January 17, 2019

Located on the top floor of the Peter Gilgan Centre for Research and Learning, SPARC BioCentre is a world-class facility operated by The Hospital for Sick Children. SPARC has been in continuous operation for over 27 years (albeit under different names), yet remains state-of-the-art thanks to strategic investments by SickKids and the Canada Foundation for…

Read More

Genomics at the Tipping Point – Partnering to Accelerate Market Uptake & Impact

December 13, 2018

On December 5th, 2018, Ontario Genomics hosted Genomics at the Tipping Point: Partnering to Accelerate Market Uptake & Impact, a captivating symposium focused on closing the gap between genomics innovations and market impact. A packed auditorium heard from innovators using genomics to advance the mining, agriculture and agri-food, bioengineering, natural resources and health sectors.  In…

Read More

Drug Discovery at SPARC: Enabling high-throughput biology and discovery

December 12, 2018

The SPARC Drug Discovery (DD) facility is the product of a strategic initiative made by SickKids to provide researchers access to state-of-the-art infrastructure and world-class expertise to develop robust and predictive assays to identify small molecule modulators of biochemical targets and/or cellular phenotypes relevant to human disease. To this end, over the past decade, SPARC-DD…

Read More

Welcome Filippo Miglior and Nezar Rghei!

December 4, 2018

It is with great pleasure that we welcome Filippo Miglior and Nezar Rghei to the Ontario Genomics team. Nezar joined us on December 3rd as Vice President Strategic Partnerships & Resource Development, and Filippo will join us on January 7th as Chief Scientific Officer and Vice President, Sector Innovation and Programs. We live in the most interesting of times, where scientific…

Read More

Ontario Genomics welcomes two new board members and appoints Interim Chair

November 7, 2018

Ontario Genomics is pleased to announce the appointment of Dr. Tom Corr and Dr. Diane Gosselin to its Board. These highly accomplished individuals bring a wealth of insight, experience and expertise in areas crucial to our business that will contribute to fulfilling the mission and achieving the strategic objectives of Ontario Genomics. Tom Corr is President…

Read More

The Genetic and Molecular Epidemiology Laboratory (GMEL) – Advancing the promise of personalized medicine

November 7, 2018

The Genetic and Molecular Epidemiology Laboratory (GMEL) at McMaster University is a premier genomics and proteomics facility offering a broad range of analytical services for academic and industry scientists. Established in 2009 by Guillaume Paré, MD, GMEL offers a broad array of cutting-edge “omics” platforms and technologies for high-throughput analyses of nucleic acids and protein…

Read More

Revealing the molecular mystery of human liver cells

November 7, 2018

A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.

Read More